Work

PI3K/Akt/mTOR pathway as a target for cancer therapy

Year: 2005

Type: review

Source: Anti-Cancer Drugs

DOI: 10.1097/01.cad.0000173476.67239.3b

Authors: Daniel Morgensztern, Howard L. McLeod

Institutions: Washington University in St. Louis, St. Louis VA Medical Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Institute of General Medical Sciences

Awards: Functional Polymorphism Analysis in Drug Pathways, Cancer Center Support Grant

OpenAlex ID: W1977943009

FWCI: 1.545

Cites: 73

Cited by: 476

Related to: 9